arrow_back Back to App

Strengthening US Drug Production: Pharmaceutical Supply Chain Security

This act establishes a commission to assess and strengthen the security of the pharmaceutical supply chain in the United States. The goal is to reduce reliance on foreign manufacturers and ensure citizens have access to essential medicines, even in challenging circumstances.
Key points
Establishment of a commission to evaluate vulnerabilities in the domestic pharmaceutical supply chain.
Development of plans to increase the production of key drug ingredients in the US.
Exploring ways to use healthcare programs to support domestic drug manufacturing.
Identifying facilities that can be repurposed for domestic drug production.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_4449
Sponsor: Rep. Torres, Ritchie [D-NY-15]
Process start date: 2023-06-30
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Pharmaceutical Security Production Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_4449.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-06-30.

What are the main provisions?

Key points include:

  • Establishment of a commission to evaluate vulnerabilities in the domestic pharmaceutical supply chain.
  • Development of plans to increase the production of key drug ingredients in the US.
  • Exploring ways to use healthcare programs to support domestic drug manufacturing.
  • Identifying facilities that can be repurposed for domestic drug production.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Torres, Ritchie [D-NY-15].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

CATEGORIES

Health Economy Security